Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
Crossref DOI link: https://doi.org/10.1007/s11239-016-1446-0
Published Online: 2016-11-28
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zirlik, Andreas
Bode, Christoph
License valid from 2016-11-28